- •The All-Ireland Cancer Consortium led to:
- ○Increased research outputs on the island of Ireland.
- ○Enhanced collaboration.
- ○Improved citations and enhanced impact.
- ○Improved cancer services and increased cancer survival.
In 1999, a cooperative tripartite cancer research and training agreement was signed between Ireland (IE), Northern Ireland (NI) and the United States (US) National Cancer Institute, giving rise to the All-Ireland Cancer Consortium (AICC). We wished to consider if AICC increased the amount/impact of cancer research on the island of Ireland and what effect this enhanced research activity had on cancer services and cancer outcomes.
As comparator, we chose the city regions of Copenhagen and Lund & Malmö, whose physical connection was greatly improved following construction of bridges between Denmark and Sweden around the time AICC was established. We analysed cancer research outputs from all four geographical regions in the Web of Science (1988–2017), with a particular focus on citations and journal impact factors. We evaluated disability-adjusted life years (DALYs) as an indicator of change in health status.
Research outputs increased in all four regions, but more in IE/NI than in the Scandinavian cities, while collaboration between IE and NI and both the US and the Rest of Europe increased even more substantially. Citation scores also showed a greater improvement for IE and NI. Journal citation impact factors indicated that IE/NI papers were increasingly being published in more highly cited journals. Research-enabled cancer service provision improved on the island of Ireland, with concomitant increases in cancer survival.
The AICC collaborative agreement delivered significant additionality on the island of Ireland, promoting transnational cooperation, enhancing cancer research activity, and underpinning improved cancer services and better cancer outcomes.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Cancer
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The NCI-Ireland consortium: a unique international partnership in cancer care.Oncol. 2001; 6: 453-458
- Mapping the European cancer research landscape: an evidence base for national and Pan-European research and funding.Eur J Canc. 2018; 100: 75-84
- Definition of cancer research: journals, titles, abstracts or keywords?.DESIDOC J Libr Inf Tech. 2011; 31: 333-339
- Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: the Northern Ireland Comprehensive Cancer Program.Cancer. 2016; 122: 664-673
- Building a 'Repository of Science': the importance of integrating biobanks within molecular pathology programmes.Eur J Canc. 2016; 67: 191-199
- Integrating molecular diagnostics into histopathology training: the Belfast model.J Clin Pathol. 2014; 67: 632-636
- Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.BMJ. 2010; 341: c3620
- Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.Lancet. 2018 Mar 17; 391: 1023-1075
Published online: February 27, 2020
Accepted: January 21, 2020
Received: January 17, 2020
© 2020 Elsevier Ltd. All rights reserved.